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Abstract
Background: This paper reports on the feasibility and initial efficacy of a culturally sensitive, comprehensive
women-centered substance use intervention for women who inject drugs in Georgia in terms of the primary and
secondary sex risk outcomes. The hypothesis under examination was that, relative to case management participants,
participants in a culturally sensitive, comprehensive women-specific and -centered intervention would, on average,
show significant decreases in past-30-day frequency of unprotected sex, unprotected sex at the last sexual encounter,
and increases in condom use and safer sex actions.
Methods: The study was a two-arm randomized trial, in which 173 potentially eligible women were screened,
and those 128 women determined to be eligible were assigned at random to either Reinforcement-based Treatment
plus Women’s Co-Op (RBT +WC) or case management (CM). RBT +WC participants received 12 sessions of a structured
intervention with the goal of reducing risky sex and substance use and improving physical and mental health. CM
participants received 12 sessions of case management and informational brochures that focused on the same
issues on which RBT + WC focused. Participants were assessed at baseline, post-treatment, and 3 months
following treatment enrollment.
Results: Analyses revealed case management having significantly overall higher Safer Sex action scores than
RBT + WC, and a significant decrease over time for past 30-day number of unprotected sex acts. Unprotected sex
at the last encounter and Condom Use action scores were nonsignificant.
Conclusions: Women who inject drugs in Georgia are engaging in risky sexual practices, and are in need of an
intervention that addresses these risky behaviors. Reasons for the failure to find differences between a culturally
sensitive, comprehensive women-centered intervention and case management tailored to the needs of women
who inject drugs in Georgia may have been the result of inadequate power to detect an effect in a sample whose
drug use was not as serious as warranted by the intervention. (ClinicalTrials.gov Identifier: NCT01331460)
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Background
Substance use disorders are a worldwide problem [1].
According to the World Health Organization “Opiates
and opioids top the list of problem drugs that cause the
most burden of disease and drug-related deaths world-
wide” [1]. International guidelines exist for the treat-
ment of opioid use disorder, [2] although the United
States has witnessed the preponderant amount of re-
search related to the treatment of opioid use disorder.
Moreover, although the World Health Organization has
focused attention on the treatment of pregnant women
with substance use disorders [3], little attention has been
paid to the development of women-centered treatment for
substance use disorders in Georgia, despite documenta-
tion of the unique needs of women in substance use treat-
ment [4], and research in the US that has shown that
treatments that focus on the issues more commonly found
in women with substance use disorders may be more effi-
cacious [5–7]. Despite the confluence of findings in this
regard in the US, and the increasing emphasis on women’s
issues by the US Substance Abuse and Mental Health
Services Administration (for example, Women Matter [8]),
international research that has focused on the develop-
ment and validation of women-centered treatments for
women with substance use disorders has not been wide-
spread, although there have been substantive efforts to de-
velop such treatments [9–14]. Of particular note in regard
to the present paper is the development of a comprehen-
sive, women-centered intervention for women who inject
drugs in Georgia [15].
Women who inject drugs in Georgia encounter continu-
ing stigma and discrimination. Women have few oppor-
tunities to receive publicly funded substance use treatment
services in Georgia. Women represent approximately 10 %
of the substance-using adult population [16, 17], yet
only 1-5 % of the beneficiaries of substance use treat-
ment services are women [18, 19]. If available, sub-
stance use treatment services in Georgia have been
designed to serve male beneficiaries, and fail to address
the unique needs and challenges that women who in-
ject drugs face in their daily lives. Our own research
[20] found that health service providers to substance-
using women believed that drug dependence in women
is much more severe than in men. Most providers believed
that substance-using women were failures as mother, wife,
and child. Moreover, substance-using Georgian women
often report that that there are no available treatment
programs that would address the specific needs of
women [21].
Moreover, women who inject drugs in Georgia fre-
quently experience emotional abuse, and physical and
sexual abuse and violence [21]. These behaviors on the
part of their husbands and sexual partners reflect a cul-
tural and social environment that engenders male
dominance and places restrictions on female equality
and independence [22]. Moreover, women have been
able to experience a broader range of social roles, and
an attendant increase in employment opportunities,
given the recent economic distress in Georgia. These
changing sex roles have often lead to men attempting to
reassert their positions of power and dominance through
the use of physical force [23, 24], leading to heightened
risk of abuse, particularly sexual abuse, given the attend-
ant increased risk of HIV and HCV transmission from
infected partners, due to inability to negotiate safe sex
practices out of fear of abuse [21].
Not surprisingly, injection drug use among adults in
Georgia has been associated with HIV infection [25],
with women comprising 26.5 % out of the total number
of registered cases. Among the 4930 HIV-positive cases
registered with the National AIDS Centre by April
2015, 48.7 % were identified as injection-drug-using in-
dividuals [26]. Although the overall HIV prevalence in
Georgia is low, the number of HIV-positive individuals
registered with the National AIDS Centre rose at least
5–10 % annually between 1994 and 2009 [27], adding
to the concern regarding an HIV epidemic in Georgia
[28].
As in Western countries, injection drug use has also
been closely tied with hepatitis C virus (HCV) infection.
HCV seroprevalence among injection-drug-using adults
in Georgia has been estimated to be 50-70 % [25, 29].
Although the HCV seroprevalence rate among injection-
drug using adults in Tbilisi, capital city of Georgia was
recently found to be significantly lower in women than
in men [30], the rates for both men (95.0 %) and women
(58.8 %) were alarmingly high.
The focus of the IMEDI (Investigating Methods for
Enhancing Development in Individuals: IMEDI is the Geor-
gian word for hope) project, funded by the US National In-
stitute on Drug Abuse (R01 DA029880) in July, 2010,
was on the development of a women-specific and -cen-
tered intervention with the objective of reducing HIV
and HCV in women who inject drugs. IMEDI had two
goals. The first goal was to gain the necessary know-
ledge from women who inject drugs and treatment pro-
viders about drug use, HIV risk behaviors, and the
current drug treatment in Georgia. The second goal
was to use this information to adapt, integrate, and im-
plement a comprehensive treatment program that com-
bines two efficacious interventions to slow the
transmission of HIV and HCV in Georgia.
In order to address its twin goals, four different IMEDI
studies focused on four separate aims (see Fig. 1). The
first two studies involved collection and analysis of data
from interviews with women who inject drugs [21], and
with health care providers [20] who provide services to
these women. These first two studies provided data to
Jones et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:47 Page 2 of 15
guide the development of a culturally sensitive, compre-
hensive, women-centered intervention for women who
inject drugs. The aim of the third study [15] was the cyc-
lical refinement and adaption of this intervention. The
aim of the fourth study was to examine the feasibility
and initial efficacy of the experimental intervention.
This paper reports on the feasibility and initial efficacy of
our culturally sensitive, comprehensive, women-centered
intervention in terms of the primary and secondary sex risk
outcomes. The hypothesis under examination was that,
relative to case management participants, participants in
the culturally sensitive, comprehensive women-specific and
-centered intervention would, on average, show significant
decreases in past-30-day frequency of unprotected sex, un-
protected sex at the last sexual encounter, and increases in
condom use and safer sex actions.
Methods
This study was approved by the Office of Human Re-
search Ethics Institutional Review Board (IRB) at the
University of North Carolina at Chapel Hill, USA
and the IRB at the Maternal and Child Care Union,
Georgia. All participants provided written informed
consent at study entry.
Study design
The study was a two-arm randomized trial. Women who
met eligibility criteria and provided informed consent
were administered a baseline assessment. After comple-
tion of the baseline assessment, they were randomized
into either the experimental or control intervention
condition. Women in both arms were offered two ses-
sions a week for 6 weeks. Follow-up assessments were
scheduled immediately after treatment completion and
again 3 months following enrollment.
Study site
An office suite with sufficient space for treatment and
research was rented in the Saburtalo district of Tbilisi.
This location was chosen because it had no previous asso-
ciation with substance use treatment services, in order to
minimize barriers for participants to enter and complete
the intervention.
Recruitment
The IMEDI project had both a Community Advisory
Board (CAB) and a Beneficiary Advisory Board (BAB).
The CAB consisted of 11 members with expertise in
health of and services to injection-drug-using women, in-
cluding substance use treatment providers, professionals
working in prisons and law enforcement, women’s vio-
lence intervention, providers of family planning and other
aspects of women’s reproductive health, counselors that
provide HIV and STI counseling, HIV prevention ser-
vices, women in the Global Fund’s Country Coordinat-
ing Mechanism who oversee HIV and tuberculosis
Fig. 1 Overall design of the IMEDI project. Figure 1 in Jones HE, Kirtadze I, Otiashvili D, O’Grady KE, Murphy K, Zule W, Krupitsky E, Wechsberg
WM. Process and product in cross-cultural treatment research: development of a culturally sensitive women-centered substance use intervention
in Georgia. J Addict Sep 2014;Article ID 163603 © 2104 by Hendrée E. Jones et al. Used with permission
Jones et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:47 Page 3 of 15
prevention and treatment programs in Georgia, and the
director of a methadone maintenance program. The mem-
bers of the BAB were 4 injection-drug-using women. The
CAB and BAB provided input into all phases of the pro-
ject. Based on their input, a number of sites in Tbilisi and
Gori that substance-using women were known to fre-
quent were identified.
Outreach workers used venue-based sampling methods
to recruit participants at the identified sites. Venue-based
sampling [31] is a time-space sampling method that in-
volves identifying the days and times members of the
population of interest assemble at a particular location,
and randomly selecting members of the population
present for screening or participation.
In the present study, consistent with venue-based
sampling, sampling methods were adapted to fit the
conditions at each site. Outreach workers were trained
in the recruitment procedures and protocols and the
recruitment procedure was scripted in a manual. They
used standardized street outreach techniques to recruit
injection-drug-using women at each site. A field screening
instrument was used to make the initial determination of
eligibility and refer potential participants to the study field
office for the final determination. Eligibility criteria were:
conversant in Georgian; minimum 18 years of age; able to
provide informed consent; injection of illicit drugs in the
past 30 days as verified by venipuncture stigmata; and
self-report of heterosexual activity at least once in the past
30 days.
A research assistant at the field office who met with the
potential participation and determined that she was eli-
gible for study participant opened an opaque sealed enve-
lope that indicated assignment to treatment condition.
Envelopes were prepared by non-clinical project staff who
had no participant contact using a block randomization
procedure to assign each successive pair of participants to
each of the treatment conditions.
No participant in this study had enrolled in a previous
IMEDI project study.
Treatment conditions
The experimental condition was developed specifically for
this study, based on information gathered in the three pre-
vious IMEDI studies, Reinforcement-based Treatment plus
Women’s Co-Op (RBT +WC) (see Table 1). RBT +WC
represented an integration of RBT, a social-learning-
theory-driven, evidence-based drug treatment intervention
that employs life skills training, recreational therapy, and
employment as components of a comprehensive treatment
model, and WC, an intervention based in feminist theory
and empowerment theory and principles of social cogni-
tive theory. As noted in Fig. 1, two qualitative studies were
conducted prior to the development of RBT+WC in
order to determine the treatment needs of injection-drug-
using women in Georgia, and also how to best tailor an in-
tegrated RBT and WC treatment approach consistent with
Georgian culture, with a particular focus on the substance-
using behaviors, sexual practices, and treatment needs of
injection-drug-using women in Georgia. Moreover, feed-
back from our CAB, BAB, and focus groups with
injection-drug-using women on the treatment manuals
and intervention materials was used to further tailor
the treatment to the Georgian culture, with a focus on
the problems and issues of substance-using women in
Georgia. In addition, as shown in Fig. 1, a pilot study
was conducted in order to further revise and adapt
RBT +WC, with additional feedback from our CAB,
BAB, and pilot study participants. As a result of these
three studies, a 12-sessions structured intervention,
RBT +WC, was developed (see Fig. 2). The goals of the
intervention were to reduce risky sex and substance
use, and to improve physical and mental health.
The control intervention was case management (CM).
However, because there were no case management ser-
vices available in Georgia for substance-using women, it
was necessary to develop a case management interven-
tion. The CM intervention that was developed followed
the general thrust of case management offered in the
US. CM participants received 12 sessions of case man-
agement and informational brochures that focused on
the same issues on which RBT +WC focused.
More complete details about both interventions can be
found in Jones et al. [15]
Assessment schedule
Sexual activity of the participants were measured at
baseline (study entry), post-treatment (end of the sched-
uled treatment, regardless of whether or not the partici-
pant completed treatment), and 3-month following
treatment entry (whether or not the participant com-
pleted treatment)..
Women who completed treatment were assessed im-
mediately at the end of treatment. Women who
dropped out of treatment before the 12th session were
contacted and asked to return to the study site to
complete their assessment. All women were contacted
prior to their 3-month follow-up date and reminded to
return to the study site for their follow-up assessment.
Participants who failed to show for their scheduled
post-treatment or follow-up appointments were con-
tacted and their appointment re-scheduled.
Measures
Outcomes were derived from the Revised Risk Behavior
Assessment (RRBA) that had been developed for re-
search in Russia [12]. The RRBA has 10 sections with
questions about demographics and social characteristics,
physical and mental health, health knowledge, alcohol
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and substance use, risky substance and sex risk practices,
power and empowerment, conflict and victimization.
The primary sex-risk outcome was measured by the
RRBA question, “Of those times you had sex with your
main sex partner in the past 30 days, how many times
did you have unprotected sex (e.g., without a condom)?”.
A second RRBA no-yes (0:1 scored) item, “The last time
you had sex with your main partner did you use a male
condom?” was used to measure one of the three second-
ary sex-risk outcomes. The two other secondary sex-risk
outcomes were derived from 11 no-yes (0:1 scored)
items on the RRBA in response to the stem “In the past
month did you:”. The sum of 3 items (“Ask your main
sexual partner to use a condom?”, “Use a condom with
your main sexual partner even if you were high on
drugs?”, and “Refuse to have sex if your main sexual
partner wouldn’t wear a condom?”) was used to measure
Condom Use actions, and the sum of 8 items (“Ask your
main sexual partner how many sex partners he has
had?”, “Ask your main sexual partner if he ever injected
drugs?”; “Ask your main sexual partner if he has ever
shared injections?”; “Ask your main sexual partner if he
has ever had an STI?”; “Ask your main sexual partner if
he has HIV?”; “Ask that your main sexual partner get
tested for HIV?”; “Ask that your main sexual partner get
tested for STIs?”; and “Ask your main sexual partner if
he has had sex with someone else?”) was used to meas-
ure Safer Sex actions.
Statistical analysis
The design of the study was a 2 (Treatment Condition:
RBT +WC v. CM) X 3 (assessment Time point: base-
line v. post-treatment v. 3-month follow-up) factorial.
Effects of interest were the main effects of Treatment
Condition and Time, and their interaction. Outcome
measures were of three types: a discrete variable in the
frequency domain (frequency of unprotected sex in the
past 30 days), assumed to follow a Poisson distribution;
a binary variable of status of protected sex at the last sex-
ual encounter, assumed to follow a binomial distribution;
and the Condom Use actions and Safer Sex actions
Table 1 Theoretical Foundations of RBT and WC
RBT: Treatment Plan and Goals
Drug abstinence is the primary treatment plan focus. A Functional
Assessment determines problem areas associated with drug use and is
the basis for other goals. The individualized treatment plan focuses on
goals directly related to decreasing/eliminating drug use. The priority
of goals is dynamic, based on most pressing issues for drug
abstinence initiation and continuation.
RBT: Reinforcing Small Goals to Reach the Large Goal
RBT is an active therapeutic approach. Each large treatment plan goal
is broken into small steps. Progress of smaller and then larger goal
behaviors are graphed at each visit (see below). Active counselor
support overcomes “resistance” due to past failures.
RBT: Density of Alternative Reinforcers
RBT increases the density of alternative (non-drug) reinforcers in the
person’s naturalistic environment. Thus, participants complete interest
inventories and Functional Assessments with their counselor to determine
what activities might serve as positive reinforcers and during periods of
previous abstinence what activities or events were functioning as
competing alternative reinforcers. Based upon urine tests negative for
monitored substances (opioids, amphetamines, benzodiazepines, THC,
buprenorphine and methadone), participants receive reward cards that
have monetary value and exchangeable for goods and services.
RBT: Response to Drug Use and Proactive Outreach
Having participants provide urine samples twice weekly during
treatment maximizes the ability to detect non-compliance when/if it
occurs and can prevent lapses from escalating to relapses. A stimulant-
positive urine test results in an individual lapse-focused counseling session
(e.g., Functional Assessment; FA) and a “time out” from other RBT aspects.
A missed RBT session results in proactive counseling outreach procedures
that same day.
RBT: Graphing of Progress
Behaviors emitted that are congruent or incongruent with goals are
graphed by the counselor with the participant. Frequent and consistent
graphing of target behaviors helps to focus both counselor and participant
on the tasks of treatment and also serves to provide “early warning signs”
that precede a lapse or relapse. Graphing is a therapy process and does
not constitute outcome measurement.
RBT: Skills Training in Recreation, Life Goals, and Other Life Skills
RBT delivers skills training in an individual or group format, with similar
efficacy. Skills-training takes the form of recreational activity sampling,
Social Club, and 12 educational modules (each topic is repeated three
times during the 12 weeks). Each skill element is manualized, an approach
previously found to be acceptable to participants.
WC: Reductions in Sex Risk and Interpersonal Violence
Four modules from Women’s Co-op were incorporated in RBT +WC.
Module 1 educates women about the risks involved in alcohol and drug
abuse and how certain sex behaviors increase HIV risk. Module 2 was
adapted to focus on the context of sexual risk for women in Georgia,
and was revised to include information gained in studies 1 and 2 (e.g.,
stigma, double-standards for men and women in number of sexual
partners). During this time, participants are asked to practice the
mechanics of correct use of male and female condoms using penile
and vaginal models. Each woman has her own model to work with
and has an opportunity to take home male and female condoms
and experience them and return the next session to discuss how it
felt to insert a female condom if they had never seen or used one.
Module 3 teaches participants negotiation skills to be used with
male partners and role-playing and rehearsal for practice. It directly
addresses fears about intimate partner violence related to forced and
unsafe sex practices and sexual negotiation. Module 4 focuses on
interpersonal violence prevention, including domestic violence and
rape, and strategies for violence prevention. Nonviolent resolutions
are presented including a process with steps for “fair fighting” to
Table 1 Theoretical Foundations of RBT and WC (Continued)
address conflict resolution. Because the Women’s Co-op modules
were a key new component of RBT + WC, it was imperative that their
messages were interwoven into RBT rather than having the modules
seen as independent, parallel or add-on. Thus, to integrate this effective
HIV prevention into RBT, we reinforced the Women’s Co-op messages in
the individual counseling sessions by graphing the frequency of safe
and unsafe sex acts, discussing condom use and condom protection
negotiations, and employing a functional analysis when unprotected
sexual acts were reported.
Note. Appendix 1 in Jones HE, Kirtadze I, Otiashvili D, O’Grady KE, Murphy K,
Zule W, Krupitsky E, Wechsberg WM. Process and product in cross-cultural
treatment research: development of a culturally sensitive women-centered
substance use intervention in Georgia. J Addict Sep 2014;Article ID 163603 ©
2104 by Hendrée E. Jones et al. Used with permission
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Fig. 2 RBT + WC intervention modules: source and adaptation. Figure 2 in Jones HE, Kirtadze I, Otiashvili D, O’Grady KE, Murphy K, Zule W,
Krupitsky E, Wechsberg WM. Process and product in cross-cultural treatment research: development of a culturally sensitive women-centered
substance use intervention in Georgia. J Addict Sep 2014;Article ID 163603 © 2104 by Hendrée E. Jones et al. Used with permission
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continuous measures, each assumed to follow a normal
distribution. In the case of frequency of unprotected sex
in the past 30 days, frequency of sexual intercourse in the
past 30 days served as a covariate. Because all outcomes
were measured repeatedly, all effects were tested using a
Generalized Estimating Equations (GEE) approach. Tests
of all effects were score χ2 tests. All analyses were
conducted with SAS 9.3 [32]. All GEE analyses used
all data that were available from participants for a
given outcome.
Power
The set correlation method [33] was used to determine
the minimum effect size in the population necessary to
detect an effect 80 % of the time with α = .05 for a sam-
ple size of 128 participants. The resulting effect sizes
were f2 = .048 for the Treatment Condition main effect
and f2 = .065 for the Time main effect and the Treatment
Condition X Time interaction effect. The Time main ef-
fect and the Treatment Condition X Time interaction ef-
fect share the same effect size because they have the
same degrees of freedom. These effect sizes fall in the
small-to-medium range, with f2 = .02 considered a
“small” effect and f2 = .15 a “medium” effect [33]. In
other words, and imprecisely, under the assumption that
the effect in the population was ≥ .048 or ≥ .065, for the
Treatment Condition, and the Time and Treatment
Condition X Time effects, respectively, there is, in the
long run, an 80 % chance of concluding that the respect-
ive effect is significant if α was set to .05 and data were
provided by 128 participants.
Results
Participants
The number of women screened was 173, of whom 128
met eligibility criteria. The 45 ineligible women screened
out of the study because of: no drug use (n = 5), non-
verifiable injection-drug-use status (n = 25), not sexually
active in the past 30 days (n = 4), and no injection drug
use and not sexually active (n = 11). Of the 128 women
who entered the trial, 114 (89 %) had injected heroin,
104 (81 %) had injected buprenorphine, 96 (75 %) had
injected the homemade amphetamine-type stimulants
‘Vint’ or ‘Jeff ’, and 78 (61 %) had injected the home-
made opioid desomorphine ‘crocodile’, with first injec-
tion at 26.3 years of age (SD = 8.1), with a friend as the
person most likely to have helped them first inject (n =
75, 59 %). All women had a history of injection drug use,
43 (34 %) had a history of needle sharing, 3 (2 %) were
HIV-positive by Western blot testing at study entry, 66
(52 %) were HCV-positive by Eliza testing at study entry,
and they had a mean number of days of opioid use in
the past 30 days of 10.9 (SD = 10.8). Of the 128 women
who entered the trial, 113 (88 %) completed treatment,
112 (88 %) were assessed at post-treatment, and 113
(88 %) were assessed at 3-month follow-up.
Table 2 presents demographic and background infor-
mation on the 128 participants, while Table 3 presents
information regarding their sexual history. Participants
were predominantly Georgian, fairly well educated,
largely unemployed, generally unmarried but in a long-
term sexual relationship. They typically engaged in
sexual intercourse for the first time in their teen years
[M = 18.2 (SD = 3.3), 73 % at 19 years of age or youn-
ger, range: 12–30]. Most women used condoms infre-
quently, although almost 20 % worried about the sexual
fidelity of their partner and almost 20 % reported having
had sex with what in Georgia is known as a “secret sex
partner”, someone other than their main sex partner, and
without his knowledge. Many of them reported using
drugs before or during their last sexual contact. Many
participants reported that their main sex partner was
often verbally abusive, but their partners were infre-
quently physically abusive. Finally, they were generally
knowledgeable about HIV, with a mean score of 8.2
(SD = 1.7; range: 3–11) on an measure of HIV know-
ledge that contained 11 true-false questions: "People
with HIV always look skinny and sick" (15 % incorrect);
"An HIV positive woman can pass the virus to her baby
before it is born" 22 % incorrect); "Babies can get HIV/
AIDS through breast feeding from their HIV-infected
mothers" (26 % incorrect); "A couple who both have
HIV do not need to use condoms" (50 % incorrect);
"People with HIV/AIDS are more likely to get TB (bad
cough, shortness of breath, night sweats)" (18 % incor-
rect); "There are medicines that a pregnant HIV posi-
tive woman can take to keep from giving HIV to her
baby" (38 % incorrect); "Blood (including menstrual)
can transmit HIV to someone else" (4 % incorrect);
"Sperm and female discharge can transmit HIV to
someone else" (4 % incorrect); "Spit can transmit HIV
to someone else" (49 % incorrect); "Injecting drug users
can transmit HIV by sharing needles" (4 % incorrect);
"Antiretrovirals (ARV) and other drugs to treat AIDS
can protect a baby from HIV" (41 % incorrect).
Psychometric characteristics of the condom use and safer
Sex measures
Both these measures showed excellent internal consistency
reliability (at baseline, treatment completion, and 3-month
follow-up: αs = .84, .86, and .92; and .87, .89, and .91,
respectively), although the means of both measures
were low [at baseline, treatment completion, and 3-month
follow-up: Condom Use M (SD; range) = .6 (1.0; 0–3), .6
(1.1; 0–3), and .4 (1.0; 0–3); Safer Sex M (SD; range) = 1.2
(2.0; 0–8), .8 (1.8; 0–8), and 1.0 (2.1; 0–8), respectively].
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Table 2 Baseline Demographic and Background Variables for the Study Entry Sample, the Samples that Completed and Failed to























Variable M (SD) or n (%) p M (SD) or n (%) p
Age 41.2 (10.0) 41.8 (10.1) 36.9 (8.6) 0.07 42.0 (10.1) 40.4 (10.0) 0.36
National Origin: – 0.78
Georgian 114 (89.1 %) 99 (87.6 %) 15 (100 %) 56 (87.5 %) 58 (90.6 %)
Russian 5 (3.9 %) 5 (4.4 %) 0 3 (4.7 %) 0
Armenian 1 (0.8 %) 1 (0.9 %) 0 1 (1.6 %) 2 (3.1 %)
Other 8 (6.3 %) 8 (7.1 %) 0 4 (6.3 %) 4 (6.3 %)
Education: – 0.48
Incomplete school 8 (6.3 %) 8 (7.1 %) 1 (6.3 %) 4 (6.3 %) 4 (6.3 %)
Completed school 36 (28.1 %) 31 (27.4 %) 5 (33.3 %) 20 (31.3 %) 16 (25.0 %)
Current student 4 (3.2 %) 4 (3.5 %) 0 2 (3.1 %) 2 (3.1 %)
Incomplete university 11 (8.6 %) 9 (8.0 %) 2 (13.3 %) 3 (4.7 %) 8 (12.5 %)
Completed university 53 (41.4 %) 48 (42.5 %) 5 (33.3 %) 27 (42.1 %) 26 (40.7 %)
Incomplete further degree 1 (0.8 %) 0 1 (6.7 %) 1 (1.6 %) 0
Completed further degree 13 (10.2 %) 11 (9.7 %) 2 (13.3 %) 6 (9.4 %) 7 (10.9 %)
Other 2 (1.6 %) 2 (1.8 %) 0 1 (1.6 %) 1 (1.6 %)
Employment status: 0.74 1
Full-time 6 (4.7 %) 6 (5.3 %) 0 3 (4.7 %) 3 (4.7 %)
Part-time 7 (5.5 %) 7 (6.2 %) 0 4 (6.3 %) 3 (4.7 %)
Part-time, self-employed 7 (5.5 %) 5 (4.45 %) 2 (13.3 %) 2 (3.1 %) 5 (7.8 %)
Student 1 (0.8 %) 1 (0.9 %) 13 (86.7 %) 1 (1.6 %) 0
Other 2 (1.6 %) 2 (1.8 %) 0 2 (3.1 %) 0
Unemployed 105 (82.0 %) 92 (81.4 %) 52 (81.3 %) 53 (82.8 %)
Marital status: – 0.74
Married to main
sexual partner
38 (29.7 %) 36 (31.9 %) 2 (13.3 %) 21 (32.8 %) 17 (26.6 %)
Living with main
sexual partner
30 (23.4 %) 28 (24.8 %) 2 (13.3 %) 15 (23.4 %) 15 (23.4 %)
Not living with main
sexual partner
56 (43.8 %) 46 (40.8 %) 10 (66.7 %) 26 (40.6 %) 30 (46.9 %)
No main sexual partner 4 (3.1 %) 3 (2.7 %) 1 (6.7 %) 2 (3.1 %) 2 (3.1 %)
Number of years been
together with main
sex partner (n = 124)
9.4 (10.6) 10.0 (10.8) 5.2 (7.4) 0.09 10.5 (11.7) 8.3 (9.1) 0.27
Living with anyone
who uses drugs: Yes
52 (40.6 %) 47 (41.6 %) 5 (33.3 %) 0.59 21 (32.8 %) 31 (48.4 %) 0.11
Number of times main
sex partner used drugs in
the past 30 days (n = 122)
8.3 (9.8) 8.3 (9.8) 8.6 (9.7) 0.92 7.3 (10.9) 9.3 (9.0) 0.25
How many friends
would you be able
to ask for help
2.8 (2.6) 2.7 (2.6) 3.8 (2.9) 0.15 3.0 (2.5) 2.7 (2.8) 0.49
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Results of inferential analyses
Tables 4 and 5 detail the GEE results. Analyses re-
vealed two significant findings: (1) A main effect for
Treatment Condition, with CM having significantly
overall higher Safer Sex actions [M = 1.2 (SE = 0.2)] than
RBT +WC [M = 0.7 (SE = 0.2)], χ2(1) = 4.83, p = .03, likely
due to the fact that the CM mean is significantly [χ2(1) =
4.32, p < .04] higher than the RBT +WC mean at baseline,
and non-significantly higher at post-treatment and 3-
month follow-up; and, (2) a significant Time main effect,
with a decrease over Time for past 30-day number of un-
protected sex acts [M = 8.5 (SE = 0.6) at baseline, M = 6.1
(SE = 0.5) at post-treatment, and M = 6.6 (SE = 0.4) at 3-
month follow-up], χ2(2) = 31.21, p < .001. Post hoc tests of
the Time main effect means revealed a significant decline
of more than 20 % in the number of past-30-day unpro-
tected sex acts from baseline to post-treatment, χ2(1) =
16.16, p < .001, and from baseline to 3-month follow-up,
χ2(1) = 9.61, p < .002. The post-treatment mean and 3-
month follow-up mean were not significantly different
from each other, χ2(1) = 0.79, p = .37. Unprotected sex
at the last encounter and Condom Use actions were
nonsignificant (ps > .15 for all effects), with the pre-
dicted probability of unprotected sex at the last en-
counter in the total sample equal to .77 (SE = .19).
Table 4 repeats all tests of significance for Treatment
Condition, Time, and Treatment Condition X Time re-
ported in this paragraph, as well as the Treatment Con-
dition, Time, and Treatment Condition X Time test
statistics and p-values for all nonsignificant effects for
the primary outcome variables, while Table 5 repeats
the means and standard errors reported here, as well as
for all nonsignificant Treatment Condition, Time, and




Most of the women in this study reported only engaging
in sex with their main partner, and they reported using
condoms infrequently. Overall, 75 % of the sample first
became sexually active with their husbands. Only 20 %
reported a secret (i.e., an extramarital/outside) sex part-
ner, and only 7 % reported that their most recent inter-
course was with someone other than their main sex
partner. Moreover, 77 % of participants reported using
substances before or during their last sexual intercourse,
and they reported that 51 % of their partners had used
substances before or during intercourse. Under these cir-
cumstances, it is not surprising that 79 % reported not
using a condom the last time they had sex.
Although women reported that their main sex part-
ners were often verbally abusive, they also reported that
their main sex partners rarely were physically intimidat-
ing or abusive to them. This relatively low level of ex-
posure to violence is decidedly different than samples
of substance-using women in the US, where rates of
physical and sexual violence exceed 80 % [34].
Feasibility of RBT +WC
Findings would suggest that implementation of cultur-
ally sensitive, women-focused treatment in Georgia can
be successfully undertaken. We were able to screen 173
women using venue-sampling methods, and recruit 128
women during a 12-month recruitment period, from 1
April 2013 to 15 April 2014. Moreover, 113/128 (88 %)
completed treatment, and 112 (88 %) and 113 (88 %)
provided post-treatment and 3-month follow-up data,
respectively. Although the trial was relatively short-
term in its focus on outcomes, these percentages are
Table 2 Baseline Demographic and Background Variables for the Study Entry Sample, the Samples that Completed and Failed to
Complete Treatment, and the Reinforcement-based Treatment and Case Management Samples at Baseline (N = 128) (Continued)
How many of these
friends currently use
drugs or alcohol
1.2 (2.2) 1.1 (2.1) 1.9 (2.9) 0.15 1.2 (2.0) 1.2 (2.4) 0.87
Notes. Likelihood ratio exact tests were used for categorical variables, and t tests for continuous variables. Percentages represent column percentages for the
respective variable. Percentages do not total to 100 % due to rounding. – indicates a test was not conducted because a cell(s) had expected count(s) less than 5,
and as such an asymptotic likelihood ratio exact test might not yield a valid test of significance. Tests for national origin were between Georgian and non-
Georgian groups (collapsing the Russian, Armenian, and Other groups into a non-Georgian group). Tests for education status were between completed school,
incomplete university/technical study, completed university/technical study, and further degree groups (ignoring the n = 6 participants in the incomplete school, stu-
dent and other groups). Tests for employment status were between unemployed and other groups (collapsing the employed full-time, employed part-time,
self-employed part-time, student and others into the other group). Test for marital status were between the married to main sexual partner, living with main
sexual partner, and having a main sexual partner not living with him groups (ignoring the n = 4 participants with no main sexual partner). Missing data were
as follows: 4 participants with no main sexual partner, leading to missing information on questions regarding number of years with main sexual partner and number of times
main sexual partner used drugs in the past 30 days, which had 2 additional cases of non-response, and as such – in the Completed Treatment sample, 4 participants were
missing data on number of years with main sexual partner and 5 participants on number of times main sexual partner used drugs in the past 30 days and in the Failed to
Complete Treatment sample, 1 participant was missing information on number of times main sexual partner used drugs in the past 30 days; and in the RBT
Condition, 2 participants were missing data on number of years with main sexual partner and 4 participants on number of times main sexual partner used drugs in the
past 30 days, while in the Usual Care Condition, 2 participants each were missing data on number of years with main sexual partner and on number of times
main sexual partner used drugs in the past 30 days, respectively
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Table 3 Baseline Sexual History for the Study Entry Sample, the Samples that Completed and Failed to Complete Treatment, and

















Sample (n = 64)
Case Management




Variable M (SD) or n (%) p M (SD) or n (%) p
Age at first vaginal sex 18.2 (3.3) 18.3 (3.6) 17.7 (3.3) 0.55 18.1 (3.3) 18.4 (3.4) 0.62
Person with whom first
vaginal sex was experienced:
– 0.67
Husband 96 (75 %) 85 (75.2 %) 11 (73.3 %) 48 (75.0 %) 48 (75.0 %)
Boyfriend 27 (21.1 %) 23 (20.4 %) 4 (26.7 %) 12 (18.8 %) 15 (23.4 %)
Stranger 1 (0.8 %) 1 (0.9 %) 0 0 1 (1.6 %)
Friend of family 1 (0.8 %) 1 (0.9 %) 0 1 (1.6 %) 0
Other 3 (2.3 %) 3 (2.7 %) 0 3 (4.7 %) 0
More than 1 sex partner in
the past 30 days: yes
7 (5.5 %) 6 (5.3 %) 1 (6.7 %) – 5 (7.8 %) 2 (3.1 %) –
Number of times had sexual
intercourse in the past 30 days
11.6 (11.0) 12.1 (11.5) 8.9 (5.9) 0.3 11.5 (13.9) 11.7 (7.3) 0.92
Number of times of unprotected
sexual intercourse in the past 30 days
9.9 (11.7) 10.5 (12.1) 5.9 (7.6) 0.15 10.2 (14.2) 9.7 (8.6) 0.82
Condom use at last sexual
intercourse with main partner: yes
25 (20.2 %) 18 (16.4 %) 7 (50.0 %) – 11 (17.7 %) 14 (22.6 %) 0.66
Main sex partner is having sex with
someone else:
1 0.01
Definitely yes 10 (8.1 %) 9 (8.2 %) 1 (7.1 %) 9 (14.5 %) 1 (1.6 %)
Probably yes 13 (10.5 %) 11 (10.0 %) 2 (14.3 %) 7 (11.3 %) 6 (9.7 %)
Probably not 19 (15.3 %) 18 (16.4 %) 1 (7.1 %) 5 (8.1 %) 14 (22.6 %)
Definitely not 82 (66.1 %) 72 (65.4 %) 10 (71.4 %) 41 (66.1 %) 41 (66.1 %)
Lifetime ever sexual intercourse
with a secret sex partner: yes
25 (19.5 %) 21 (18.6 %) 4 (26.7 %) 0.74 13 (20.3 %) 12 (18.8 %) 1






13 (86.7 %) – 58 (90.6 %) 61 (95.3 %) 0.49
Drug use just before or during
last sex: yes
98 (76.6 %) 86 (76.1 %) 12 (80.0 %) – 46 (71.9 %) 52 (81.3 %) 0.3
Partner drug use just before
or during last sex: yes
65 (50.8 %) 59 (52.2 %) 6 (40.0 %) 0.42 29 (45.3 %) 36 (56.3 %) 0.29




93 (82.3 %) 8 (53.3 %) – 52 (81.3 %) 49 (76.6 %) 0.67
HIV Knowledge 8.2 (1.7) 8.3 (1.7) 7.9 (1.4) 0.42 8.1 (1.7) 8.3 (1.6) 0.61
In the past 30 day did your main
sex partner:
insult you or make you feel
bad about yourself?
32 (25.8 %) 28 (25.5 %) 4 (28.6 %) – 16 (25.8 %) 16 (25.8 %) 1
belittle or humiliate you in front
of other people?
10 (8.1 %) 8 (7.3 %) 2 (14.3 %) + D27 – 6 (9.7 %) 4 (6.5 %) 0.74
do things to scare or intimidate
you on purpose for example
by the way he looked at you,
by yelling and smashing things?
6 (4.8 %) 6 (5.5 %) 0 – 4 (6.5 %) 2 (3.2 %) –
threaten or hurt you? 3 (2.4 %) 3 (2.7 %) 0 – 3 (4.8 %) 0
stopped from seeing any of
your friends?
0 0 0 0 0
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excellent, given drop-out rates for outpatient substance
use treatment have been estimated at 23-50 % [35].
We have discussed one of the striking cultural differ-
ences between research in the US and research in
Georgia in a previous publication, [15] where we noted
that research is a novel experience to the Georgian
populace, and so Georgian women whom we have re-
cruited have often been quite interested in helping our
efforts to conduct our research and collect data. This
phenomenon may have in part contributed to our suc-
cess in both recruitment into the study and retention of
participants, and collection of follow-up data.
Efficacy of RBT +WC
Results did not support the efficacy of RBT +WC rela-
tive to case management in regard to risky sexual behav-
ior. The fact that the CM condition had higher scores
on the Safer Sex measure than did the RBT +WC condi-
tion is likely due to pretreatment differences between
the two conditions – the CM Safer Sex means are higher
than the RBT +WC means at all three assessments.
Moreover, there was only one significant result indicat-
ing change over time in participant’s sex-risk behavior,
for number of unprotected sex acts during the preceding
30-day period. Taken together, these findings suggest
Table 3 Baseline Sexual History for the Study Entry Sample, the Samples that Completed and Failed to Complete Treatment, and the
Reinforcement-based Treatment and Usual Care Samples at Baseline (N = 128) (Continued)
slap you or throw something
at you that could have hurt you?
5 (4.0 %) 5 (4.6 %) 0 – 3 (4.8 %) 2 (3.2 %) –
hit you with a fist or with something
else which could hurt you?
0 0 0 0 0
push or shove you? 1 (0.8 %) 1 (0.9 %) 0 – 0 1 (1.6 %) –
kick, drag, beat, choke or burn you? 0 0 0 0 0
threaten to use or actually use a gun,
knife or other weapon against you?
0 0 0 0 0
physically force you to have sex
when you did not want to?
1 (0.8 %) 1 (0.9 %) 0 – 1 (1.6 %) 0 –
did you have sex with your main
sexual partner when you did not
want to because you were afraid of
what he might do?
1 (0.8 %) 1 (0.9 %) 0 – 1 (1.6 %) 0 –
force you to have anal (i.e., bum) sex 0 0 0 0 0
Notes. Likelihood ratio exact tests were used for categorical variables, and t tests for continuous variables. Percentages represent column percentages for the
respective variable. Percentages do not total to 100 % due to rounding. – indicates a test was not conducted because a cell(s) had expected count(s) less than 5,
and as such an asymptotic likelihood ratio exact test might not yield a valid test of significance. Missing data were as follows: 4 participants had no main sexual
partner (see Table 2), leading to missing information on the questions regarding condom use at last sexual intercourse with main partner, main sex partner is
having sex with someone else, and in the past 30 day did your main sex partner, and as such 3 participants in the Completed Treatment sample and 1
participant in the Failed to Complete Treatment sample were missing data on these variables; and 2 participants each in the RBT and Usual Care Conditions
were missing data on these variables
Table 4 Results of Inferential Analyses for Primary and Secondary Sex-Risk Outcome Measures (N = 128)
Treatment Condition Time Treatment Condition X Time
χ2 p χ2 p χ2 p
Primary Outcomes
Past-30-day frequency of unprotected sexual
intercourse
1.64 0.2 31.21 <.001 1.47 0.48
Secondary Outcomes
Unprotected sex at the last encounter: yes 0.03 0.87 2.78 0.25 0.79 0.68
Condom Use Actions 0.02 0.89 2.71 0.26 3.76 0.15
Safer-sex Actions 4.83 0.03 2.29 0.32 1.81 0.4
Notes. N = 124 (128–4 with no main sex partner) at baseline; for secondary outcomes, N = 96 (128–16 with no main sex partner and 16 failed to return for
assessment) at post-treatment assessment, and N = 86 (128–27 with no main sex partner and 15 failed to return for assessment) at 3-month follow-up assessment,
while for the primary outcome, N = 92 (128–16 with no main sex partner and 16 failed to return for assessment plus an additional 4 participants who had a main
sex partner who declined to answer these two questions) at post-treatment assessment and N = 74 (128–27 with no main sex partner and 15 failed to return for
assessment plus an additional 12 participants who had a main sex partner who declined to answer these two questions). df = 1 for Treatment Condition, df = 2 for
Session, and df = 2 for Treatment Condition X Session. Past-30-day number of times engaging in unprotected intercourse was a count variable assumed to follow
a Poisson distribution, unprotected sex at the last encounter was a binary variable assumed to follow a binomial distribution, and condom self-efficacy and safe-sex self
efficacy were continuous variables assumed to follow a normal distribution
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that the participants did not change their risky sexual
behavior during the course of treatment, irrespective of
whether it was RBT +WC or case management, with the
possible exception of the finding that weakly suggests
that RBT +WC and CM were equally effective in produ-
cing change in risky sexual behavior over the course of
the study – or, alternatively, that participants might have
somehow been sensitized to the need to use condoms
due to participation in the study. It is particularly dis-
tressing that the Condom Use and Safer Sex means in
the total sample were quite low throughout the study.
However, it is possible than many of the participants
were in longer-term relationships and had already
learned the injection drug use and HIV status of their
partners, and so did not believe it necessary to use a
condom for STI protection. We did not directly assess
trust in the relationship. We do note that although the
predicted probability of unprotected sex at the last sex-
ual encounter in the total sample was .77, while, as
Table 3 notes, the percentage of participants who indi-
cated that their main sexual partner was “probably not”
having sex with someone else was 15 % and “definitely
not” having sex with someone else was 66 %, a combined
percentage of 81 %, the relationship between these two
variables was nonsignificant.
It is also the case that the majority women in Georgia
(58 %) have historically never utilized any method of
contraception, with the estimate in 2005 of women not
currently using any contraceptive method of 72 % [36].
Moreover, the use of condoms in 2005 among Georgian
women was estimated at 9 % [37]. Thus, historical
forces, together with a strong Georgian Orthodox op-
position to the use of birth control methods, may have
also operated to blunt the impact of our intervention –
although it was the case that the women as a group did
engage in unprotected sexual intercourse less frequently
at the conclusion of the study and at 3-month follow-up
that at baseline assessment, suggesting the possibility of
some impact of exposure to information about condom
use that was available in both treatment conditions.
In considering future research examining the efficacy of
RBT +WC, the open question is whether RBT +WC
could be effective with a different population of injection-
drug-using women in Georgia, and/or whether RBT +WC
needs to be further tailored to increase its impact on
injection-drug-using women in Georgia. Although our
goal was to sample broadly among injection-drug-using
women in Georgia, our sample was largely composed of
injection-drug-using women who were in relatively stable
relationships with a single male sex partner. Thus, the goal
of RBT +WC to increase condom use could have been
blunted by the fact that the sample as a whole felt little
need to change their condom use practices, given long-
term and generally exclusive heterosexual relationships.
We need to determine whether the sample we recruited
represents the dominant percentage of injection-drug-
using women in Georgia, or whether this population has,
as we had expected, a large percentage of women who
have no stable heterosexual partner. If the former cir-
cumstance is true, then we would need to further
adapt RBT +WC so it addressed the needs of injection-
drug-using women with a stable heterosexual sex partner.
Table 5 Means (Standard Errors) from Inferential Analyses for Primary and Secondary Sex-Risk Outcome Measures (N = 128)
Treatment
Condition
























8.5 (0.6) 6.1 (0.5) 6.6 (0.4) 7.8 (0.7) 5.6 (0.6) 6.5 (0.7) 9.2 (0.8) 6.8 (0.6) 5.7 (0.6)
Secondary Outcomes








0.7 (0.04) 0.8 (0.04) 0.8
(0.05)
0.7 (0.04) 0.8 (0.06) 0.8
(0.05)
0.7 (0.06) 0.8 (0.06)









1.1 (0.2) 0.8 (0.2) 0.9 (0.2) 0.7 (0.2) 0.6 (0.2) 0.6 (0.3) 1.4 (0.3) 0.9 (0.2) 1.3 (0.3)
Notes. RBT = Reinforcement Based Treatment. N = 124 (128–4 with no main sex partner) at baseline; for secondary outcomes, N = 96 (128–16 with no main sex
partner and 16 failed to return for assessment) at post-treatment assessment, and N = 86 (128–27 with no main sex partner and 15 failed to return for assessment)
at 3-month follow-up assessment, while for the primary outcome, N = 92 (128–16 with no main sex partner and 16 failed to return for assessment plus an additional 4
participants who had a main sex partner who declined to answer these two questions) at post-treatment assessment and N = 74 (128–27 with no main sex partner and
15 failed to return for assessment plus an additional 12 participants who had a main sex partner who declined to answer these two questions). Model-estimated means
for the Poisson variable (past-30-day frequency of unprotected sexual intercourse) have been back-transformed into the metric of the original variables.
Model-estimated means for the binomial variable (unprotected sex at the last encounter) are the predicted probabilities
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Such an intervention could be tailored along the lines of
the couple-based intervention developed by El-Bassel,
Gilbert, and colleagues [38–42]. Tailoring could be
based in part on our own research with treating female
partners of opioid-injecting men in Georgia [43]. If the
later circumstance is true, we would want to further ex-
plore the efficacy of the current version of RBT +WC.
Limitations
There were several limitations to the present study. First,
the recruitment strategy may or may not have recruited
a sample representative of women in Georgia who
injected substances. However, there are so few women
who inject drugs in treatment in Georgia [21] that it
would not be possible to recruit a sample from women
seeking treatment for their drug use – although it is
likely that this sample would be representative of women
in Georgia who inject drugs. Nonetheless, the recruit-
ment strategy and our resulting sample limits our ability
to generalize our findings to women who inject drugs in
Georgia. Second, the sample size was relatively small, as
one of the primary goals of the study was to assess the
feasibility of the intervention. Accordingly, we had lim-
ited power to detect small intervention effects. Third, it
is possible that the active ingredients in the case man-
agement intervention developed as the control condition
specifically for this study were sufficiently impactful that
differences between the RBT +WC condition were mini-
mized, adversely affecting the ability to detect an effect.
However, not offering some form of treatment to the
control condition participants would have been uneth-
ical. Finally, despite the fact that the RBT +WC inter-
vention was developed on the basis of data collected in
three previous studies with the goal of meeting the
needs of injection-drug-using women in Georgia, it is
possible that the RBT +WC intervention was not suffi-
ciently tailored to their needs.
Implications for prevention and policy
Unsurprisingly, the main implication for prevention is
that there is strong need for changes in both public pol-
icy and public health that recognize the need for con-
dom use. In some ways, injection-drug-using women
would seem to recognize the greater need for the use of
condoms than occurs in the general Georgian female
population, given the fact the percentage in the general
population was less than 10 % in 2005. However, that an
estimated 77 % of a high-risk population did not use a
condom at their most recent sexual encounter is alarm-
ing. Yet public policy and public health efforts to en-
courage condom use are at odds with the position of the
Georgian Orthodox Church regarding contraception,
which it condemns. The issue is further compounded by
the fact that, although the rate of HIV infection is
steadily rising in Georgia, the absolute number of cases
remains low, [26] meaning that public attention has
largely not focused on HIV infection as a problem facing
general society. The problem is then further com-
pounded by the fact that injection-drug-using women
are highly stigmatized in Georgian culture, extending
even to health service providers [20]. Otiashvili and col-
leagues [44] have identified four areas of concern in de-
veloping successful treatment programs in Georgia for
injection-drug-using women: sociocultural issues; pol-
icy issues; programmatic/structural issues; and per-
sonal/Interpersonal Issues, and have suggested that
solutions must be sought in four areas: public health cam-
paigns; development and implementation of comprehen-
sive women-specific confidential treatment models; policy
reform; and empowering women. More complete details
of needed reforms to the service delivery system in
Georgia can be found in their article.
Conclusions
Women who inject drugs in Georgia are engaging in
risky sexual practices, and are in need of an interven-
tion that addresses these risky behaviors. Neither a
comprehensive women-centered intervention based on
the twin platforms of RBT and WC – two interventions
that have been successfully adapted to treatment in
international settings – nor case management tailored
to the needs of women who inject drugs in Georgia was
effective in changing risky sexual behaviors. Whether
the sample size was insufficient to detect an effect,
whether the effect size was smaller than anticipated,
and/or whether the sample did not come from a popu-
lation for which the intervention would be efficacious
are open questions. Our previous research has sug-
gested the importance of social, cultural, and treatment
provider barriers to treatment entry and treatment re-
tention for injection-drug-using women in Georgia and
outlined further directions for treatment [44]. Further
research focusing on the circumstances under which
women who inject drugs in Georgia continue to engage
in risky sexual behaviors needs to be undertaken in
order to revise RBT +WC so that it can lead to changes
in these behaviors. In particular, it may be that RBT +
WC would be effective with Georgian women without a
stable sexual partner who inject drugs and engage in
sexual activity. In regard to both of these missions, it
might be important to ‘expand the lens’ and focus more
broadly on women in the Southern Caucasus region,
and determine commonalities and unique characteris-
tics associated injection drug use by women in the
region as a way to better develop a comprehensive
women-centered intervention for this highly stigma-
tized and highly vulnerable population.
Jones et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:47 Page 13 of 15
Competing interest
None of the authors have any competing interests.
Authors’ contributions
HEJ designed the study and wrote the first draft of the manuscript. IK and
DO collaborated with HEJ in designing the study, and oversaw collection
of the data. KM was responsible for study oversight. KEO’G conducted the
statistical analyses. WZ, EK, and WMW collaborated with HEJ in the design
of the study. All authors contributed to the drafting of the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
The authors thank IMEDI project staff for making the study possible, and
participants for their valuable time and effort.
Financial disclosures
Supported by NIDA grant R01 DA029880 (Hendrée E. Jones, PI). NIDA played
no role in: 1) study design; 2) collection, analysis, and interpretation of data;
3) writing of the report; or 4) decision to submit or where to submit the
poster for presentation.
Author details
1UNC Horizons, Department of Obstetrics and Gynecology, School of
Medicine, University of North Carolina at Chapel Hill, 127 Kingston Drive,
Chapel Hill, NC 27514, USA. 2Departments of Psychiatry and Behavioral
Sciences and Obstetrics and Gynecology, School of Medicine, Johns Hopkins
University, Baltimore, MD 21224, USA. 3Addiction Research Center, Alternative
Georgia, Tbilisi 0177, Georgia. 4Ilia State University, Business School, Tbilisi
0162, Georgia. 5Department of Psychology, University of Maryland, College
Park, College Park, MD 20742, USA. 6Substance Abuse Treatment Evaluations
and Interventions Research Program, RTI International, Research Triangle Park,
NC 27709, USA. 7Department of Addictions, Bekhterev Research
Psychoneurological Institute, St. Petersburg 192019, Russia.
Received: 16 July 2015 Accepted: 23 November 2015
References
1. World Health Organization, World Drug Report 2014. Available from https://
www.unodc.org/documents/data-and-analysis/WDR2014/World_Drug_
Report_2014_web.pdf.
2. World Health Organization, Guidelines for the psychosocially assisted
pharmacological treatment of opioid dependence. 2009. Available
from http://www.who.int/substance_abuse/publications/opioid_
dependence_guidelines.pdf
3. World Health Organization. Guidelines for the identification and
management of substance use and substance use disorders in pregnancy.
2014 November 24, 2014. Available from: http://apps.who.int/iris/bitstream/
10665/107130/1/9789241548731_eng.pdf.
4. Center for Substance Abuse Treatment. Substance abuse treatment:
Addressing the specific needs of women. Treatment Improvement Protocol
(TIP), vol. 51. Rockville, MD: Substance Abuse and Mental Health Services
Administration; 2009.
5. Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women.
Psychiatr Clin North Am. 2010;33(2):339–55.
6. Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, et al.
Substance abuse treatment entry, retention, and outcome in women: a
review of the literature. Drug Alcohol Depend. 2007;86(1):1–21.
7. Greenfield SF, Grella CE. What is "women-focused" treatment for substance
use disorders? Psychiatr Serv. 2009;60(7):880–2.
8. Substance Abuse and Mental Health Services Administration. Women
Matter. Women, Children & Families 2015 1 October 2015. Available from:
http://www.samhsa.gov/women-children-families/trainings/women-matter.
9. Wechsberg WM, Browne FA, Poulton W, Ellerson RM, Simons-Rudolph A,
Haller D. Adapting an evidence-based HIV prevention intervention for
pregnant African-American women in substance abuse treatment. Subst
Abuse Rehabil. 2011;2:35–42.
10. Wechsberg WM, Jewkes R, Novak SP, Kline T, Myers B, Browne FA, et al. A
brief intervention for drug use, sexual risk behaviours and violence
prevention with vulnerable women in South Africa: a randomised trial of
the Women's Health CoOp. BMJ Open. 2013;3(5).
11. Wechsberg WM, Jones HE, Zule WA, Myers BJ, Browne FA, Kaufman MR,
et al. Methamphetamine ("tik") use and its association with condom use
among out-of-school females in Cape Town, South Africa. Am J Drug
Alcohol Abuse. 2010;36(4):208–13.
12. Wechsberg WM, Krupitsky E, Romanova T, Zvartau E, Kline TL, Browne FA,
et al. Double jeopardy - drug and sex risks among Russian women who
inject drugs: initial feasibility and efficacy results of a small randomized
controlled trial. Subst Abuse Treat Prev Policy. 2012;7:1.
13. Wechsberg WM, Luseno WK. The need for culturally appropriate, gender-
specific global HIV prevention efforts with vulnerable women. J Prev Interv
Community. 2010;38(2):85–8.
14. Jones HE, Myers B, O'Grady KE, Gebhardt S, Theron GB, Wechsberg WM.
Initial feasibility and acceptability of a comprehensive intervention for
methamphetamine-using pregnant women in South Africa. Psychiatry J.
2014;2014:929767.
15. Jones, HE, Kirtadze I, Otiashvili D, O'Grady KE, Murphy K, Zule W et al.
Process and product in cross-cultural treatment research: development of a
culturally sensitive women-centered substance use intervention in Georgia J
Addict, 2014. Article ID 163603.
16. Needle RH, Zhao L. HIV Prevention among Injection Drug Users
Strengthening U.S. Support for Core Interventions. A Report of the CSIS
Global Health Policy Center. Available from http://csis.org/files/publication/
100408_Needle_HIVPrevention_web.pdf.
17. Zaalishvili L, Chachanidze M, Mchedlishvili N. Female drug users in Georgia:
Needs Assessment: Tbilisi, Georgia Harm Reduction Network 2013.
18. Javakhishvili D, Kirtadze I, Otiashvili D, Sturua L. Drug Situation in Georgia,
Annual Report 2013. 2015: Tbilisi, Georgia. ISBN: 978-9941-07851-4.
19. Javakhishvili J, Sturua L. Drug Situation in Georgia - 2008. Tbilisi: Southern
Caucasus Anti-Drug Programme; 2009.
20. Kirtadze I, Otiashvili D, O'Grady KE, Zule W, Krupitsky E, Wechsberg WM,
Jones HE. Twice stigmatized: provider's perspectives on drug-using women
in the Republic of Georgia. J Psychoactive Drugs. 2013;45(1):1–9.
21. Kirtadze I, Otiashvili D, O'Grady KE, Zule W, Krupitsky E, Wechsberg WM,
Jones HE. Women who inject drugs in the republic of Georgia: in their own
words. J Psychoactive Drugs. 2015;47(1):71–9.
22. Nizharadze G, Stvilia K, Todadze K. HIV and AIDS in Georgia: A Socio-Cultural
Approach. UNESCO, 2005. Available from http://unesdoc.unesco.org/
images/0014/001411/141169M.pdf.
23. Chitashvili M, Javakhishvili N, Arutiunov L, Tsuladze L, Chachanidze S.
National Research on Domestic Violence against Women in Georgia. 2010
April 5, 2015; Available from: http://www2.ohchr.org/english/bodies/cedaw/
docs/AdvanceVersions/GeorgiaAnnexX.pdf
24. Ubilava N, Chabukiani N, Jibladze G. The Anti-Domestic Violence Policy
Analysis in Georgia. A report of Women’s Fund in Georgia. 2014 May 11,
2015]; Available from: http://www.crrc.ge/uploads/files/conference/
conference_2014/UbilavaJibladzeChabukiani-paper.pdf.
25. Chkhartishvili N, McNutt LA, Smith PF, Tsertsvadze T. Characteristics of
HIV-infected women and factors associated with HCV seropositivity in
the Republic of Georgia. AIDS Res Ther. 2011;8(1):25.
26. Georgian AIDS and Clinical Immunology Centre, HIV/AIDS
Epidemiology in Georgia. 2015. Available at http://aidscenter.ge/
epidsituation_eng.html.
27. Government of Georgia, UNGASS Country Progress Report, Reporting Period
2008 – 2009 calendar years. 2010: Available from http://data.unaids.org/
pub/Report/2010/georgia_2010_country_progress_report_en.pdf
28. Buckley, C. The socio-cultural correlates of HIV/AIDS in the Southern
Caucasus. HIV and AIDS in the Caucasus: A Socio-Cultural Approach 2005
April 4, 2015; Available from: http://hivaidsclearinghouse.unesco.org/search/
resources/bie_141152e.pdf.
29. Javakhishvili D, Sturua L, Otiashvili D, Kirtadze I, Zabransky T. Overview of
the Drug Situation in Georgia, 2011. Addictologie. 2011;11(1):52–1.
30. Bouscaillou J, Champagnat J, Luhmann N, Avril E, Inaridze I, Miollany V, et al.
Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent
need for prevention and treatment. Int J Drug Policy. 2014;25(5):871–8.
31. Muhib FB, Lin LS, Stueve A, Miller RL, Ford WL, Johnson WD, Smith PJ. A
venue-based method for sampling hard-to-reach populations. Public Health
Rep. 2001;116(Suppl 1):216–22.
32. SAS Institute Inc. The SAS System for Windows. Release 9.3. Cary, NC: SAS
Institute; 2011.
33. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed.
Hillsdale, N.J.: L. Erlbaum Associates. xxi; 1988. p. 567.
Jones et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:47 Page 14 of 15
34. Kartha A, Brower V, Saitz R, Samet JH, Keane TM, Liebschutz J. The impact of
trauma exposure and post-traumatic stress disorder on healthcare utilization
among primary care patients. Med Care. 2008;46(4):388–93.
35. Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F. Drop-out from
addiction treatment: a systematic review of risk factors. Clin Psychol Rev.
2013;33(8):1010–24.
36. Serbanescu F, Imnadze P, Bokhua Z, Nutsubidze N, Jackson DB, Morris L.
Reproductive Health Survey, Georgia, 2005. Final report. Atlanta, Georgia,
USA: Georgian National Center for Disease Control and Centers for Disease
Control and Prevention; 2007. Available from stacks.cdc.gov/view/cdc/8275/
cdc_8275_DS1.pdf.
37. Westoff C, Serbanescu F. The Relationship between Contraception and
Abortion in the Republic of Georgia: Further Analysis of the 1999 and
2005 Reproductive Health Surveys. Calverton, Maryland, USA: Macro
International; 2008.
38. Witte SS, Wu E, El-Bassel N, Hunt T, Gilbert L, Medina KP, et al.
Implementation of a couple-based HIV prevention program: a cluster
randomized trial comparing manual versus Web-based approaches.
Implement Sci. 2014;9:116.
39. El-Bassel N, Gilbert L, Terlikbayeva A, Beyrer C, Wu E, Chang M, et al. Effects
of a couple-based intervention to reduce risks for HIV, HCV, and STIs among
drug-involved heterosexual couples in Kazakhstan: a randomized controlled
trial. J Acquir Immune Defic Syndr. 2014;67(2):196–203.
40. El-Bassel N, Gilbert L, Wu E, Witte SS, Chang M, Hill J, Remien RH. Couple-
based HIV prevention for low-income drug users from New York City: a
randomized controlled trial to reduce dual risks. J Acquir Immune Defic
Syndr. 2011;58(2):198–206.
41. El-Bassel N, Gilbert L, Witte S, Wu E, Hunt T, Remien RH. Couple-based HIV
prevention in the United States: advantages, gaps, and future directions.
J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S98–S101.
42. Gilbert L, El-Bassel N, Terlikbayeva A, Rozental Y, Chang M, Brisson A, et al.
Couple-based HIV prevention for injecting drug users in Kazakhstan: a pilot
intervention study. J Prev Interv Community. 2010;38(2):162–76.
43. Lund IO, Kirtadze I, Otiashvili D, O'Grady KE, Jones HE. Female partners of
opioid-injecting men in the Republic of Georgia: an initial characterization.
Subst Abuse Treat Prev Policy. 2012;7:46.
44. Otiashvili D, Kirtadze I, O'Grady KE, Zule W, Krupitsky E, Wechsberg WM,
Jones HE. Comprehensive women-centered treatment for substance use
disorders in Georgia: current status and future directions. J Subst Use, 2015;
20(5):367–374.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Jones et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:47 Page 15 of 15
